Immutep Limited Stock Price Prediction

PRRUF Stock  USD 0.20  0.00  0.00%   
As of 11th of December 2024, the relative strength index (RSI) of Immutep's share price is approaching 40 indicating that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Immutep, making its price go up or down.

Oversold Vs Overbought

40

 
Oversold
 
Overbought
The successful prediction of Immutep's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Immutep and does not consider all of the tangible or intangible factors available from Immutep's fundamental data. We analyze noise-free headlines and recent hype associated with Immutep Limited, which may create opportunities for some arbitrage if properly timed.
Using Immutep hype-based prediction, you can estimate the value of Immutep Limited from the perspective of Immutep response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Immutep to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Immutep because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Immutep after-hype prediction price

    
  USD 0.2  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Immutep Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immutep's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.010.173.27
Details
Naive
Forecast
LowNextHigh
00.193.29
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.180.210.25
Details

Immutep After-Hype Price Prediction Density Analysis

As far as predicting the price of Immutep at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Immutep or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Immutep, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Immutep Estimiated After-Hype Price Volatility

In the context of predicting Immutep's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Immutep's historical news coverage. Immutep's after-hype downside and upside margins for the prediction period are 0.01 and 3.30, respectively. We have considered Immutep's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.20
0.20
After-hype Price
3.30
Upside
Immutep is out of control at this time. Analysis and calculation of next after-hype price of Immutep Limited is based on 3 months time horizon.

Immutep Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Immutep is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Immutep backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Immutep, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.17 
3.10
 0.00  
  0.01 
0 Events / Month
19 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.20
0.20
0.00 
0.00  
Notes

Immutep Hype Timeline

Immutep Limited is at this time traded for 0.20. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Immutep is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at -0.17%. %. The volatility of related hype on Immutep is about 7045.45%, with the expected price after the next announcement by competition of 0.19. About 24.0% of the company shares are owned by institutional investors. The book value of Immutep was at this time reported as 0.11. The company recorded a loss per share of 0.02. Immutep Limited had not issued any dividends in recent years. The entity had 1:10 split on the 5th of November 2019. Assuming the 90 days horizon the next anticipated press release will be within a week.
Check out Immutep Basic Forecasting Models to cross-verify your projections.

Immutep Related Hype Analysis

Having access to credible news sources related to Immutep's direct competition is more important than ever and may enhance your ability to predict Immutep's future price movements. Getting to know how Immutep's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Immutep may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ZURAZura Bio Limited(0.16)8 per month 0.00 (0.07) 7.95 (8.08) 26.70 
ENVBEnveric Biosciences 0.01 6 per month 0.00 (0.11) 8.00 (7.50) 28.33 
EFTREffector Therapeutics(0.06)4 per month 0.00 (0.31) 8.70 (27.78) 88.91 
IMMXImmix Biopharma(0.14)5 per month 5.00  0.04  11.44 (8.72) 32.68 
ELEVElevation Oncology(0.03)9 per month 4.39  0.05  8.33 (8.06) 22.21 
DSGNDesign Therapeutics(0.13)5 per month 5.31  0.09  9.43 (7.45) 35.31 
ALXOAlx Oncology Holdings(0.02)8 per month 0.00 (0.08) 9.30 (9.46) 26.52 
AADIAadi Bioscience 0.04 5 per month 2.25  0.12  5.08 (3.67) 13.95 
ADCTADC Therapeutics SA(0.13)9 per month 4.60  0.06  8.41 (8.44) 60.46 
ALVRAllovir 0.01 8 per month 0.00 (0.06) 6.25 (7.55) 47.97 
SANASana Biotechnology(0.03)11 per month 0.00 (0.20) 9.02 (9.22) 25.44 
OLMAOlema Pharmaceuticals 0.84 7 per month 0.00 (0.10) 6.17 (9.21) 21.23 
CGEMCullinan Oncology LLC 0.14 9 per month 0.00 (0.17) 5.88 (7.24) 17.85 
LIFEATyr Pharma 0.03 1 per month 2.62  0.07  6.45 (5.29) 28.98 
ZNTLZentalis Pharmaceuticals Llc 0.58 8 per month 5.05  0.05  11.41 (8.20) 33.76 
CRNXCrinetics Pharmaceuticals(1.08)9 per month 2.48  0.02  2.74 (3.52) 16.75 
VRDNViridian Therapeutics(0.80)11 per month 3.06  0.09  6.84 (4.33) 44.89 
CYTKCytokinetics 2.32 11 per month 0.00 (0.10) 3.52 (3.46) 14.08 
GPCRStructure Therapeutics American 1.69 7 per month 3.50 (0.01) 8.18 (6.89) 24.50 
ICVXIcosavax(0.11)1 per month 4.56  0.13  10.22 (6.79) 38.57 
CDTXCidara Therapeutics 0.40 9 per month 2.49  0.19  12.90 (5.14) 25.29 
SLNSilence Therapeutics PLC(4.13)7 per month 0.00 (0.22) 4.70 (8.72) 41.48 
APLTApplied Therapeutics(0.32)9 per month 0.00 (0.08) 5.60 (13.79) 145.13 
CTMXCytomX Therapeutics 0.01 10 per month 3.33 (0.02) 6.78 (5.22) 22.92 
CELLPhenomeX(0.03)1 per month 0.00 (0.21) 6.52 (9.26) 21.32 

Immutep Additional Predictive Modules

Most predictive techniques to examine Immutep price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Immutep using various technical indicators. When you analyze Immutep charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Immutep Predictive Indicators

The successful prediction of Immutep stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Immutep Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Immutep based on analysis of Immutep hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Immutep's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Immutep's related companies.

Story Coverage note for Immutep

The number of cover stories for Immutep depends on current market conditions and Immutep's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Immutep is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Immutep's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Immutep Short Properties

Immutep's future price predictability will typically decrease when Immutep's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Immutep Limited often depends not only on the future outlook of the potential Immutep's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Immutep's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding866.2 M

Complementary Tools for Immutep Pink Sheet analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
CEOs Directory
Screen CEOs from public companies around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance